SolarDx is a new low cost disruptive technology with potential applications in a number of areas which include health, agriculture, and water and sanitation. DIV is providing $150,000 to support A'as to validate the technical viability of SolarDx as a point of care diagnostic tool (for example, TB, HIV, STI’s. HPV, HCV, and Hepatitis) that is more accurate and portable, and allows results to be conveyed to the patients immediately.